Dr. Ron Najafi,
Dr. Ramin (“Ron”) Najafi is the Founder & CEO of Emery Pharma (www.emerypharma.com)
An accomplished entrepreneur and scientist, Dr. Najafi has founded four companies, and has held numerous executive and scientific roles in the biopharmaceutical industry over the past 25 years.
In 2000 Dr. Najafi founded NovaBay Pharmaceuticals. During his tenure at NovaBay, he took the company from concept to IPO, successfully raising $15 million privately before raising $20 million during a cross-border IPO in the United States and Canada. Dr.
Najafi successfully raised over $200 million in public and private investment to help build NovaBay.
Dr. Najafi led NovaBay’s partnership efforts, securing significant collaboration agreements with Galderma S.A., the world’s leading dermatology company, and Alcon Laboratories Inc., the leading ophthalmology company. Dr. Najafi also served in various management positions within NovaBay, including as Chief Scientific Officer. He helped NovaBay achieve significant breakthroughs in the discovery of the company’s Aganocide® and Neutrox technologies which led to NeutroPhase and Avenova.
Prior to founding NovaBay, Dr. Najafi was the president and CEO of CP Lab Safety, Inc., a chemical laboratory safety devices company manufacturing his invention Ecological Funnels and now distributing over 40,000 products worldwide.
He has also held scientific roles at Rhône Poulenc Rorer (now Sanofi-Aventis), Perkin Elmer Applied Biosystems (now Thermo Fisher), and Aldrich Chemical Company. He was selected as the outstanding scientist at Perkin-Elmer Applied Biosystems and the Recipient of Perkin-Elmer President’s Award for Innovative Discoveries in Chemistry (September 1995) amongst 1300 PhD’s.
Dr. Najafi has more than 70 patents and pending patent applications on his inventions. He received B.S. and M.S. degrees in chemistry from the University of San Francisco, and a Ph.D. in organic chemistry from the University of California at Davis.